Upstream Bio (UPB) Other financing activities (2024 - 2026)

Upstream Bio (UPB) posted quarterly Other financing activities of $598000.0 for Q1 2026, up 150.85% quarter-over-quarter from -$1.2 million in Q4 2025.

Upstream Bio (UPB) Other financing activities (2024 - 2026) Analysis & Trends

Upstream Bio's Other financing activities history runs 3 years deep, the most recent figure standing at $598000.0 for Q1 2026.

  • In Q1 2026, Other financing activities changed N/A year-over-year to $598000.0; the TTM figure through Mar 2026 stood at $794000.0 (down 99.71% YoY), while the FY2025 annual figure was $196000.0, down 99.93% from the prior year.
  • Other financing activities for Q1 2026 stood at $598000.0, up from -$1.2 million in the prior quarter.
  • The five-year high for Other financing activities was $272.6 million in Q4 2024, with the low at -$1.2 million in Q4 2025.
  • The 3-year median for Other financing activities is $349000.0 (2024), against an average of $34.2 million.
  • Peak annual rise in Other financing activities reached 3900.0% in 2025, while the deepest fall reached 100.43% in 2025.
  • Upstream Bio's Other financing activities stood at $272.6 million in 2024, then sank by 100.43% to -$1.2 million in 2025, then jumped by 150.85% to $598000.0 in 2026.
  • Business Quant data shows UPB's Other financing activities at $598000.0 in Q1 2026, -$1.2 million in Q4 2025, and $760000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Upstream Bio 387.23 Mn 387.23 Mn -3.29 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 450,000.00
Jun 30, 2026 450,000.00
Mar 31, 2026 598,000.00
Mar 31, 2026 598,000.00
Dec 31, 2025 -1.18 Mn
Dec 31, 2025 -1.18 Mn
Sep 30, 2025 760,000.00
Sep 30, 2025 760,000.00
Jun 30, 2025 612,000.00
Jun 30, 2025 612,000.00
Dec 31, 2024 272.59 Mn
Dec 31, 2024 272.59 Mn
Sep 30, 2024 19,000.00
Sep 30, 2024 19,000.00
Jun 30, 2024 100,000.00
Jun 30, 2024 100,000.00
Mar 31, 2024 12,000.00
Mar 31, 2024 12,000.00